BackRevance Therapeutics Overview

Revance Therapeutics Research & Development

Research & Development expenses for RVNC.

Quarterly R&D Expenses

$11.38M
↓ 12.87% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$60.21M
↓ 23.38% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin